Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 48SPRINGWORKS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 12295925

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-17

blank

02

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 12295925

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-17

blank

03

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 12295925

Drug Substance Claim :

Drug Product Claim :

Application Number : 219379

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-17

blank

04

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 11883375

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-03-16

blank

05

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 11883375

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-03-16

blank

06

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 12011424

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-17

blank

07

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 11839595

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-03-16

blank

08

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 11839595

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-03-16

blank

09

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 11819487

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-17

blank

10

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

MIRDAMETINIB

US Patent Number : 11819487

Drug Substance Claim :

Drug Product Claim :

Application Number : 219389

Patent Use Code : U-4130

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-17

blank